Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland.
S
S
de Massougnes
Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland.
F-X
FX
Borruat
Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland.
A
A
Ambresin
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D006801:Humans; D000068556:Interferon beta-1a / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D058456:Retinal Telangiectasis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000068556:Interferon beta-1a